West Paces Advisors’s Chemed CHE Stock Holding History

West Paces Advisors’s Portfolio CHE Stock Details CHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-4	Closed	-$1.9K	–	580
2021 Q2	$1.9K	Buy	+4	New	+$1.92K	﹤0.01%	547

Other funds holding CHE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

West Paces Advisors's CHE Position: Q3 2021 in Review

West Paces Advisors sold out of Chemed (CHE) in Q3 2021, closing a stake of 4 shares — an estimated $1.9K sold.

West Paces Advisors first reported a position in CHE in Q2 2021 and held it in 1 quarter. The position peaked at $1.9K in Q2 2021. 404 funds tracked by Wall St. Rank hold CHE as of Q3 2021.

West Paces Advisors reported no remaining Chemed position as of Q3 2021 after selling out during the quarter.
West Paces Advisors sold 4 Chemed shares in Q3 2021, an estimated $1.9K.
West Paces Advisors first reported a position in Chemed in Q2 2021 and held it in 1 quarter.
West Paces Advisors's Chemed position peaked at $1.9K in Q2 2021.
404 funds tracked by Wall St. Rank held Chemed as of Q3 2021.

Based on West Paces Advisors's 13F filing for Q3 2021, filed 20 Dec 2023.